Promising Cancer Treatment Targets Rare Genetic Flaw
An experimental cancer medicine called larotrectinib has shown promise treating a diverse range of cancers in people young and old, researchers said at a major cancer conference in the United States. The treatment targets a genetic abnormality which is often found in rare cancers — including salivary gland cancer, juvenile breast cancer, and a soft … Read more